Kiniksa Pharmaceuticals International, plc Debt Securities, Available-for-sale, Amortized Cost, Current
Kiniksa Pharmaceuticals International, plc (KNSA) had Debt Securities, Available-for-sale, Amortized Cost, Current of $78.84 million as of 2024-03-31, per its 10-Q filed 2024-04-25.
Discontinued › Notes
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2024-04-25
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost, Current $78.84M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $100.38M.
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost, Current $89.25M.
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $88.67M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Current |
|---|---|
| 2024-03-31 | $78.84M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $100.38M 10-Q · filed 2024-04-25 |
| 2023-09-30 | $89.25M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $88.67M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $107.85M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $82.90M 10-Q · filed 2023-11-02 |